Fountain Health Insurance utilizes advanced diagnostic technologies, including AI-guided imaging and multi-cancer early detection blood tests, to identify life-threatening conditions before symptoms arise. The platform addresses the high prevalence of undiagnosed chronic diseases, enabling personalized health plans that promote early intervention and enhance longevity.
Funding
$14.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many chronic diseases progress silently, with symptoms often appearing only in late stages when treatment options are limited. Traditional healthcare systems often lack the advanced diagnostic tools needed for early detection of life-threatening conditions. This results in delayed intervention and reduced opportunities for personalized preventative care.
Solution
Fountain Life offers a membership-based longevity program that uses advanced diagnostic technologies and personalized health plans to identify and address health risks before they become critical. The program leverages AI-guided imaging, multi-cancer early detection blood tests, and comprehensive biomarker analysis to provide a detailed understanding of each member's health status. Longevity physicians then develop personalized plans incorporating cutting-edge therapeutics and lifestyle interventions to optimize healthspan and extend lifespan. The goal is to empower individuals to take control of their health and proactively prevent or manage chronic diseases.
Target Audience
Fountain Life targets individuals who are proactive about their health and interested in leveraging advanced technologies and personalized interventions to extend their healthspan and prevent age-related diseases.
Features
- Full-body and brain MRI with AI to detect early cancers and abnormalities
- Coronary CT angiography with AI to identify vulnerable plaque and assess heart attack risk
- Multi-cancer early detection blood test screening for over 50 cancer types
- Comprehensive blood biomarker panel assessing kidney, liver function, vitamins, and hormones
- Gut and oral microbiome testing to evaluate digestive health and identify potential risks for chronic diseases
- Whole genome sequencing to detect genetic predispositions to diseases
- Toxin assessment to identify exposure to harmful chemicals and heavy metals
- Neurocognitive function testing to assess cognitive capabilities and neurological health
- Balance assessment to monitor stability, coordination, and body movement